Physician profile
Walid Alami
NPI 1003897869
$1,539.52
in general payments reported to CMS, 2019-2025
23 companies · $453 in 2025
The $453 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $549 · 2024: $334 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $236.69 | 2023 | Verquvo |
| Medtronic, INC. | $181.38 | 2022-2025 | Symplicity G3, Hawkone, Linq II |
| Abbott Laboratories | $176.43 | 2022-2025 | Thoratec Heartmate II, Lvas Implant Kit, Jot Dx |
| Pfizer INC. | $149.72 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $123.88 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $94.68 | 2024 | Farxiga |
| Irhythm Technologies, INC. | $82.98 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.25 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $58.39 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $50.60 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $42.67 | 2023-2025 | Eliquis |
| W. L. Gore & Associates, INC. | $41.66 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Lantheus Medical Imaging, INC. | $31.82 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.15 | 2025 | Jardiance |
| Abiomed | $25.31 | 2024 | Impella |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $24.10 | 2024 | Alphavac |
| Inspire Medical Systems, INC. | $22.48 | 2025 | Inspire |
| Amgen INC. | $20.29 | 2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $20.12 | 2022 | |
| Scpharmaceuticals INC. | $19.68 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $18.22 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $17.75 | 2024 | Xarelto |
| Boston Scientific Corporation | $14.27 | 2025 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walid Alami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.